Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced ...

In head-to-head clinical trial, Chinese firm Akeso’s ivonescimab beat top-selling drug pembrolizumab sold as Keytruda by Merck. Ivonescimab reduced risk of tumour progression by 49%.

The FDA has approved Keytruda in combination with pemetrexed and platinum chemotherapy, as first-line Tx of unresectable advanced or metastatic malignant pleural mesothelioma.

Among patients with high-risk muscle-invasive urothelial carcinoma, postsurgical Keytruda extended the time some lived ...

During a Case-Based Roundtable® event, Chandler Park, MD, moderated a discussion on treating patients with indolent or ...

Adjuvant cancer treatments such as chemotherapy and radiation are given after a primary cancer treatment to help prevent ...

Canada India Tech Council, in partnership with Consulate General of India (Toronto) and TheAppLabb, is proud to announce the ...

At HUAWEI CONNECT 2024, the Huawei Cloud Stack Roundtable for Global Government CIOs, with the theme, "Dive into Cloud and ...

TIME's senior sports correspondent Sean Gregory tries his hand at several Olympic sports while learning from Olympians. Subscribe now to get unlimited access to TIME.com and more! Tidal action ...

Shares of Trump Media & Technology Group Corp. slumped to their lowest level ever early Friday morning, the first day that ...

The first big update to U.S. methadone regulations in 20 years is poised to expand access to the life-saving drug starting ...

With less than 50 days until voters take to the polls, second gentleman Doug Emhoff has been on the campaign trail supporting his wife, Vice President Kamala Harris, as she campaigns to be the ...